Clinical Trial

A Study of Selective Internal Radiation Therapy for the Management of Chemotherapy-induced Thrombocytopenia With Splenomegaly in Adult Subjects With Gastrointestinal Cancer

Study acronym: SPLENIC-SIRT
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This is a prospective, interventional, open-label, single-arm, multicenter pilot study evaluating the safety, tolerability and maximum tolerated dose (MTD) of splenic Selective Internal Radiation Therapy (SIRT) using TheraSphere in adult patietns with gastrointestinal cancer and chemotherapy-induced thrombocytopenia with splenomegaly
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-05-04.
Trial Details
NCT Number NCT07575854
Lead Sponsor Centre Georges Francois Leclerc
Conditions Gastrointestinal Cancer
Enrollment 18 participants
Start Date 2026-10-01
Primary Completion 2026-12-01 (estimated)
Study Completion 2029-04-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-13